As of 2025-07-01, the EV/EBITDA ratio of Clearpoint Neuro Inc (CLPT) is -15.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CLPT's latest enterprise value is 321.20 mil USD. CLPT's TTM EBITDA according to its financial statements is -20.85 mil USD. Dividing these 2 quantities gives us the above CLPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 19.6x - 23.5x | 21.5x |
| Forward P/E multiples | 22.7x - 23.8x | 23.4x |
| Fair Price | (16.33) - (16.88) | (16.10) |
| Upside | -238.4% - -243.0% | -236.4% |
| Date | EV/EBITDA |
| 2025-06-27 | -15.41 |
| 2025-06-26 | -15.71 |
| 2025-06-25 | -15.35 |
| 2025-06-24 | -15.18 |
| 2025-06-23 | -14.81 |
| 2025-06-20 | -14.67 |
| 2025-06-18 | -14.66 |
| 2025-06-17 | -14.55 |
| 2025-06-16 | -15.14 |
| 2025-06-13 | -15.05 |
| 2025-06-12 | -15.79 |
| 2025-06-11 | -16.83 |
| 2025-06-10 | -17.43 |
| 2025-06-09 | -17.45 |
| 2025-06-06 | -18.29 |
| 2025-06-05 | -16.80 |
| 2025-06-04 | -17.02 |
| 2025-06-03 | -16.57 |
| 2025-06-02 | -15.39 |
| 2025-05-30 | -15.42 |
| 2025-05-29 | -15.64 |
| 2025-05-28 | -15.80 |
| 2025-05-27 | -16.41 |
| 2025-05-23 | -15.53 |
| 2025-05-22 | -15.79 |
| 2025-05-21 | -15.89 |
| 2025-05-20 | -16.75 |
| 2025-05-19 | -17.20 |
| 2025-05-16 | -17.28 |
| 2025-05-15 | -16.93 |
| 2025-05-14 | -16.26 |
| 2025-05-13 | -18.66 |
| 2025-05-12 | -17.90 |
| 2025-05-09 | -18.54 |
| 2025-05-08 | -18.73 |
| 2025-05-07 | -17.43 |
| 2025-05-06 | -17.18 |
| 2025-05-05 | -18.23 |
| 2025-05-02 | -18.97 |
| 2025-05-01 | -18.27 |
| 2025-04-30 | -18.92 |
| 2025-04-29 | -19.30 |
| 2025-04-28 | -19.35 |
| 2025-04-25 | -19.34 |
| 2025-04-24 | -18.78 |
| 2025-04-23 | -17.37 |
| 2025-04-22 | -16.76 |
| 2025-04-21 | -15.61 |
| 2025-04-17 | -16.00 |
| 2025-04-16 | -15.03 |